Methylethyltryptamine: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 19:03, 17 March 2025
Methylethyltryptamine (also known as MET) is a psychedelic and hallucinogenic drug. It is structurally related to dimethyltryptamine (DMT) and ethylisopropyltryptamine (EIPT), and is considered to be a member of the tryptamine class of compounds.
Chemistry[edit]
Methylethyltryptamine is a synthetic compound of the tryptamine class. Tryptamines share a core structure comprised of a bicyclic indole heterocycle attached at R3 to an amino group via an ethyl side chain. MET is substituted at R1 of its indole heterocycle with a methyl group, it also contains two ethyl chains bound to the terminal amine RN of its tryptamine backbone (MET).
Pharmacology[edit]
The pharmacology of methylethyltryptamine is not well-studied. However, like other tryptamines, it is thought to act primarily as a serotonin receptor agonist. It may also have effects on other neurotransmitter systems.
Effects[edit]
The effects of methylethyltryptamine can vary widely, depending on the dose and individual's physiology. Common effects include visual hallucinations, altered thinking processes, and a sense of euphoria. Some users also report experiencing a sense of spiritual insight or enlightenment.
Risks[edit]
As with any psychedelic drug, the use of methylethyltryptamine carries risks. These can include psychological distress, dangerous behavior, and negative physical reactions. It is also possible for the drug to interact negatively with other substances or medications.
Legal Status[edit]
The legal status of methylethyltryptamine varies by country. In some places, it is a controlled substance, while in others it is legal to possess and use.
See Also[edit]
| Psychoactive substances | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This psychoactive substance-related article is a stub.
|
